The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
21 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,553,153 in first-year total cost, median $428,141.
Most frequent study sections
- Cellular and Molecular Technologies Study Section[CMT]11
- Genomics, Computational Biology and Technology Study Section[GCAT]2
- Modeling and Analysis of Biological Systems Study Section[MABS]2
- Cellular and Molecular Immunology - A Study Section[CMIA]1
- Developmental Therapeutics Study Section[DT]1
Most frequent institutions
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)4
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY2
- RICE UNIVERSITY2
- UNIVERSITY OF TEXAS AT AUSTIN2
- CALIFORNIA INSTITUTE OF TECHNOLOGY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function1R01EB031936-01 | GILAD, ASSAF AHOCHGESCHWENDER, UTE H | CENTRAL MICHIGAN UNIVERSITY, MI | $2,026,634 | CMT |
| 2021 | A high-performance and versatile technology for precision microbiome engineering1R01EB031935-01 | STERNBERG, SAMUEL HENRYWANG, HARRIS H | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $688,498 | GCAT |
| 2021 | Synthetic gene sensors and effectors to redirect organoid development1R01EB030946-01 | BELTA, CALINKEMP, MELISSA LAMBETHWEISS, RON | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $682,610 | ZRG1 |
| 2021 | Evolution and optimization of synthetic <READ/WRITE> function from and into cells using genetic programming1R01EB030565-01 | BANZHAF, WOLFGANGGILAD, ASSAF A | MICHIGAN STATE UNIVERSITY, MI | $579,888 | CMT |
| 2021 | Directed evolution of a sequence-specific targeting technology for therapeutic gene delivery to the human genome.1R01EB031124-01 | OWENS, JESSE BRUCE | UNIVERSITY OF HAWAII AT MANOA, HI | $574,713 | GDD |
| 2021 | Programmable gene integration and cell engineering with CRISPR-directed integrases1R01EB031957-01 | ABUDAYYEH, OMAR OGOOTENBERG, JONATHAN SAMUEL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $568,123 | TAG |
| 2021 | Targeted control of self-transmissible plasmids by using engineered interfering plasmids1R01EB031869-01 | YOU, LINGCHONG | DUKE UNIVERSITY, NC | $428,141 | MABS |
| 2021 | Synthetic epigenetic circuits: tunable cell fate switches controlled by dynamic and combinatorial inputs1R01CA253017-01A1 | BARBOSA DE ALMEIDA, RICARDO AUGUSTOLIM, WENDELL A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $413,916 | CMT |
| 2021 | Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas131R01EB031904-01 | WONG, WILSON | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $396,889 | CMT |
| 2021 | A synthetic signaling pathway engineering platform for creating precision cell-based sense-and-response devices1R01EB032272-01 | BASHOR, CALEB | RICE UNIVERSITY, TX | $344,920 | CMT |
| 2021 | Engineering mammalian gene activity sensor-actuator devices1R01EB030030-01A1 | SEGATORI, LAURA | RICE UNIVERSITY, TX | $339,400 | CMT |
| 2020 | Synthetic toolkit for precision gene expression control and signal processing in mammalian cells1R01EB029483-01 | KHALIL, AHMAD SAMIR | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $704,349 | CMT |
| 2020 | Cell targeting with synthetic sense-and-respond protease circuits1R01EB030015-01 | ELOWITZ, MICHAEL B | CALIFORNIA INSTITUTE OF TECHNOLOGY, CA | $602,432 | CMT |
| 2020 | Engineering S. typhimurium for metastatic colorectal cancer1R01EB029750-01A1 | DANINO, TAL | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | $346,661 | DT |
| 2020 | Directed evolution of polymerases that can read and write extremely long sequences1R01EB027202-01A1 | ELLINGTON, ANDREW D | UNIVERSITY OF TEXAS AT AUSTIN, TX | $329,742 | GCAT |
| 2020 | Development of a mechanosensitive synthetic cell for mediating intercellular communication.1R01EB030031-01 | LIU, ALLEN PO-CHIH | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $270,490 | CMT |
| 2019 | ePACE: an automated system for high-throughput, closed-loop control of continuous molecular evolution to enable novel therapeutics1R01EB027793-01 | KHALIL, AHMAD SAMIR | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $687,081 | ISD |
| 2019 | Programmable Synthetic Organelles Built from Disordered Proteins for Cellular Engineering1R01EB028320-01 | GOOD, MATTHEW CHARLTONHAMMER, DANIEL A | UNIVERSITY OF PENNSYLVANIA, PA | $429,904 | CMT |
| 2019 | Integration of systems and synthetic biology to advance development of human tissues ex vivo1R01EB028532-01 | EBRAHIMKHANI, MO REZA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $426,312 | CMT |
| 2019 | Engineering a smart CAR platform for human regulatory T cells1R56EB027729-01A1 | DOOMS, HANS PETEREMILI, ANDREWWONG, WILSON | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $357,217 | CMIA |
| 2019 | Synthetic biology for controlled release1R01EB026533-01A1 | ELLINGTON, ANDREW D | UNIVERSITY OF TEXAS AT AUSTIN, TX | $355,233 | MABS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.